[go: up one dir, main page]

HK1261741B - 用於心血管病况的司美鲁肽 - Google Patents

用於心血管病况的司美鲁肽 Download PDF

Info

Publication number
HK1261741B
HK1261741B HK19121635.7A HK19121635A HK1261741B HK 1261741 B HK1261741 B HK 1261741B HK 19121635 A HK19121635 A HK 19121635A HK 1261741 B HK1261741 B HK 1261741B
Authority
HK
Hong Kong
Prior art keywords
semaglutide
pharmaceutical composition
use according
fatal
subject
Prior art date
Application number
HK19121635.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1261741A1 (zh
Inventor
Oluf Kristian Højbjerg HANSEN
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HK1261741A1 publication Critical patent/HK1261741A1/zh
Publication of HK1261741B publication Critical patent/HK1261741B/zh

Links

HK19121635.7A 2016-04-28 2017-04-28 用於心血管病况的司美鲁肽 HK1261741B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16167458 2016-04-28
EP16188262 2016-09-12

Publications (2)

Publication Number Publication Date
HK1261741A1 HK1261741A1 (zh) 2020-01-03
HK1261741B true HK1261741B (zh) 2022-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
US20250288649A1 (en) Semaglutide in Cardiovascular Conditions
US12233114B2 (en) Method for treating diabetes
AU2024201937A1 (en) Liraglutide in cardiovascular conditions
US11673933B2 (en) Method for using insulin degludec for the improvement of glycemic control and reduction of acute and long-term diabetes complications
HK1261741A1 (zh) 用於心血管病况的司美鲁肽
HK1261741B (zh) 用於心血管病况的司美鲁肽
US20190091295A1 (en) Liraglutide in Renal Conditions
WO2018096164A1 (en) Insulin degludec for treating diabetes
BR122025010585A2 (pt) Uso de semaglutida para reduzir o risco de um evento cardiovascular adverso maior (mace) em indivíduos com diabetes mellitus tipo 2 e alto risco cardiovascular
HK1259166A1 (zh) 用於心血管病况的利拉鲁肽
HK1259166B (zh) 用於心血管病况的利拉鲁肽